Skip to main content
Nicox S.A. logo

Nicox S.A. — Investor Relations & Filings

Ticker · COX ISIN · FR0013018124 LEI · 969500EZGEO9W4JXR353 PA Professional, scientific and technical activities
Open in API
Filings indexed 799 across all filing types
Latest filing 2023-10-02 Share Issue/Capital Cha…
Country FR France
Listing PA COX

About Nicox S.A.

https://www.nicox.com/

Nicox S.A. is an international ophthalmology company focused on the research and development of innovative therapeutic solutions to maintain vision and improve ocular health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost analog in late-stage clinical development for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Nicox's pipeline is based on its proprietary NO-donating research platform. The company has also developed two approved ophthalmic products: VYZULTA® (latanoprostene bunod ophthalmic solution), licensed exclusively to Bausch + Lomb, and ZERVIATE® (cetirizine ophthalmic solution), licensed to various partners for commercialization.

Recent filings

Filing Released Lang Actions
PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE
Share Issue/Capital Change Classification · 99% confidence The document is titled "PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE" (Monthly publication of the number of shares comprising the capital and the total number of voting rights), dated October 2, 2023, and references French regulatory articles (Code de Commerce and AMF Regulation). It explicitly reports the total number of shares and voting rights as of September 30, 2023. This type of regular, mandatory disclosure regarding the capital structure and voting rights does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory disclosure concerning share capital. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the closest fit as it deals directly with the number of shares and voting rights, which are fundamental components of the capital structure. Although it's a monthly update rather than a change announcement, it is the most relevant category for capital structure reporting.
2023-10-02 French
MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement dated October 2, 2023, titled 'MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS'. It explicitly references French regulatory articles (Code de Commerce and AMF regulations) and provides the share capital and voting rights as of September 30, 2023. This type of regular, mandatory disclosure regarding the total number of shares and voting rights aligns most closely with regulatory reporting requirements that are not covered by the more specific categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since it is a specific regulatory disclosure that doesn't fit the primary definitions (like 10-K, ER, or DIV), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous, mandatory regulatory update.
2023-10-02 English
Nicox confirme son éligibilité au PEA-PME
Regulatory Filings Classification · 100% confidence The document is titled "Communiqué de presse" (Press Release) and announces a confirmation regarding the company's eligibility for the PEA-PME investment scheme, citing specific articles from the French Monetary and Financial Code. It is a short, informational announcement dated October 2, 2023, providing a brief update on a regulatory/listing status rather than a full financial report (like 10-K or IR) or a detailed presentation (like IP). Given its nature as a general, non-financial-specific regulatory update that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), it best fits the general regulatory announcement category, which is RNS (Regulatory Filings), or potentially a general announcement if RNS is reserved for specific exchange filings. Since it is a formal press release announcing compliance/status, RNS is the most appropriate fallback for miscellaneous regulatory communications not covered elsewhere.
2023-10-02 French
Monthly Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of August 31, 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a 'MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS' as of August 31, 2023, referencing French commercial code and AMF regulations. This type of regular disclosure regarding the total number of shares and voting rights is a specific regulatory requirement. While it is a publication, it is not a general regulatory filing (RNS) or a report like 10-K or IR. It is a specific disclosure related to capital structure and voting rights, which is best categorized under Capital/Financing Update (CAP) or potentially a specific regulatory disclosure. Given the options, it most closely relates to capital structure changes or updates, but the core content is the monthly count of shares and voting rights. Since there is no specific code for 'Monthly Share Capital Publication', I must choose the closest fit. It is not a dividend announcement (DIV), director dealing (DIRS), or major shareholding notification (MRQ). It is a mandatory disclosure about the capital base. In many databases, these specific capital structure updates fall under general financing/capital updates. However, the content is purely about the count of shares and voting rights. If we look at the definitions, none fit perfectly. 'SHA' is for Share Issue/Capital Change, which this is an update on. 'MRQ' is for Major Shareholding Notification, which this is not. Given the focus on the total number of shares and voting rights, it is a fundamental capital structure disclosure. I will classify this as a Capital/Financing Update (CAP) as it directly reports on the composition of the share capital, which is a key element of financing structure, although it is a recurring monthly disclosure.
2023-09-01 English
PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 AOUT 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE" (Monthly publication of the number of shares comprising the capital and the total number of voting rights), dated September 1, 2023, referencing data as of August 31, 2023. It explicitly cites French regulatory articles (Code de Commerce and AMF regulations) requiring this disclosure. This type of regular disclosure regarding the total share count and voting rights is a specific regulatory requirement, often falling under general regulatory announcements or specific capital structure updates. Since there is no specific code for 'Monthly Share Capital Disclosure' among the provided options, and it is a mandatory regulatory disclosure, it best fits the general 'Regulatory Filings' (RNS) category, as it is not an earnings release (ER), interim report (IR), or a specific capital change like a share issue (SHA) or dividend notice (DIV). Given its nature as a mandatory, periodic regulatory update, RNS is the most appropriate fallback.
2023-09-01 French
PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE" (Monthly publication of the number of shares comprising the capital and the total number of voting rights), dated August 1, 2023, referencing data as of July 31, 2023. It explicitly cites French regulatory articles (Code de Commerce and AMF regulations) concerning the disclosure of share capital and voting rights. This type of regular, mandatory disclosure regarding the total number of shares and voting rights, often published monthly, does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory disclosure. Given the options, it is a specialized regulatory announcement. Since there is no specific code for 'Share Capital/Voting Rights Publication', and it is a formal regulatory disclosure, it falls best under the general 'Regulatory Filings' (RNS) category, as it is a mandatory filing that doesn't match the other specific definitions like Director's Dealing (DIRS) or Dividend Notice (DIV). The document length is short (1701 chars), but it is the report itself, not an announcement of another report.
2023-08-01 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.